Alexion Pharmaceuticals I... (ALXN)

AI Score

Unlock

182.50

0.00 (0.00%)

At close: Jan 01, 1970, 12:00 AM

Alexion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	3.43B	2.96B	2.27B	2.83B	2.31B	2.69B	2.17B	1.98B	1.54B	1.37B	1.23B	727.5M	511.8M	584.4M	550M	542M	713M	966M	761.99M	597.55M	710.2M
Short-Term Investments	39.7M	34.9M	28.9M	26.8M	47.8M	64M	44.4M	105.4M	110.3M	198.3M	306.2M	449.5M	1.08B	889.7M	979M	902M	749M	327M	550.88M	582.5M	317.35M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	447M	506.2M	838.8M	672M	636.1M	633.3M	878.3M	751.2M	655.8M	397.2M	401.2M	401.1M	387.7M	312.6M	338M	318M	304M	299M	262.7M	257.63M	248.5M
Receivables	1.47B	1.41B	1.44B	1.37B	1.35B	1.24B	1.12B	1.12B	1.02B	922.3M	910.2M	853.7M	776.7M	726.5M	705M	710M	660M	650M	676.84M	609.3M	586.25M
Inventory	803.9M	775.7M	729M	577.7M	586.8M	627.6M	576.7M	494.6M	482.2M	472.5M	432.7M	463.2M	456.5M	460.4M	441M	410M	396M	375M	363.06M	329.85M	293.96M
Other Current Assets	706.4M	648.6M	604.8M	566.2M	575.4M	456.1M	432.5M	460.7M	497M	426.4M	370.4M	342.2M	327.9M	292.9M	207M	225M	215M	260M	241.77M	242.01M	219.75M
Total Current Assets	6.45B	5.83B	5.07B	5.37B	4.87B	5.08B	4.34B	4.17B	3.65B	3.38B	3.25B	2.84B	3.15B	2.95B	2.88B	2.79B	2.73B	2.58B	2.59B	2.36B	2.13B
Property-Plant & Equipment	1.46B	1.46B	1.21B	1.2B	1.16B	1.16B	1.15B	1.12B	1.09B	1.47B	1.44B	1.42B	1.38B	1.32B	1.35B	1.23B	1.14B	1.04B	931.06M	825.3M	749.29M
Goodwill & Intangibles	8.15B	8.1B	8.16B	7.13B	9.26B	8.38B	8.45B	8.53B	8.6B	8.68B	8.75B	8.83B	8.91B	8.99B	9.07B	9.15B	9.26B	9.34B	9.51B	9.59B	9.68B
Total Long-Term Assets	12.2B	12.27B	12.48B	11.34B	13.28B	12.47B	10.47B	10.4B	10.35B	10.55B	10.6B	10.65B	10.68B	10.63B	10.76B	10.7B	10.7B	10.68B	10.7B	10.67B	10.67B
Total Assets	18.65B	18.1B	17.55B	16.7B	18.15B	17.54B	14.81B	14.57B	14B	13.93B	13.84B	13.49B	13.83B	13.58B	13.64B	13.49B	13.44B	13.25B	13.29B	13.03B	12.8B
Account Payables	125.3M	118.6M	89.2M	n/a	n/a	74M	n/a	728.7M	669.8M	74.4M	52.2M	58.8M	57.1M	70.8M	35M	51M	61M	64M	44.85M	28.98M	42.9M
Deferred Revenue	n/a	150.9M	n/a	n/a	n/a	103.9M	n/a	n/a	n/a	24.4M	n/a	n/a	n/a	15.9M	18M	14M	16M	37M	63.4M	53.42M	78.42M
Short-Term Debt	143.2M	142.4M	138.6M	126.8M	126.7M	126.7M	126.6M	126.6M	126.5M	343.8M	311.2M	278.5M	167.5M	167.4M	167M	167M	167M	167M	322.94M	79.14M	35.36M
Other Current Liabilities	1.16B	1.21B	1.1B	993.3M	993.2M	889.7M	964.6M	176.2M	147.5M	731.4M	664M	707.1M	717.4M	698.4M	752M	624M	593M	555M	603.15M	496.93M	446.94M
Total Current Liabilities	1.43B	1.62B	1.33B	1.12B	1.12B	1.19B	1.09B	1.03B	943.8M	1.17B	1.03B	1.04B	942M	952.5M	972M	856M	837M	823M	1.03B	658.46M	603.61M
Long-Term Debt	2.39B	2.42B	2.45B	2.31B	2.34B	2.38B	2.41B	2.44B	2.47B	2.5B	2.53B	2.56B	2.68B	2.72B	2.76B	2.8B	2.85B	2.89B	2.93B	3.17B	3.21B
Other Long-Term Liabilities	765.1M	775.3M	871M	833.9M	824.2M	622.1M	635.2M	593.2M	573.1M	699.8M	670.4M	649.7M	654M	652M	611M	567M	512M	452M	481.84M	430.38M	387.87M
Total Long-Term Liabilities	4.79B	4.83B	5.14B	5.09B	5.28B	5.08B	3.36B	3.37B	3.35B	3.59B	3.65B	3.68B	3.78B	3.74B	3.73B	3.76B	3.74B	3.74B	3.76B	4.17B	4.14B
Total Liabilities	6.22B	6.45B	6.47B	6.21B	6.4B	6.27B	4.45B	4.4B	4.29B	4.77B	4.67B	4.72B	4.72B	4.69B	4.7B	4.61B	4.58B	4.56B	4.79B	4.83B	4.74B
Total Debt	2.53B	2.56B	2.59B	2.44B	2.47B	2.5B	2.53B	2.56B	2.6B	2.85B	2.84B	2.84B	2.85B	2.89B	2.93B	2.97B	3.01B	3.06B	3.25B	3.25B	3.25B
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	23K	23K	23K
Retained Earnings	5.88B	5.24B	4.71B	4.13B	5.2B	4.64B	3.75B	3.28B	2.82B	2.33B	2.37B	2.04B	2.5B	2.24B	2.21B	2.13B	1.97B	1.82B	1.72B	1.39B	1.27B
Comprehensive Income	-85.2M	-124.6M	-119.2M	-110.9M	-101.5M	-66.8M	-48.2M	-57.9M	-20.5M	-9.7M	6.9M	-2.9M	-45.7M	-34.4M	-37M	-14M	36M	60M	-16.62M	694K	3.81M
Shareholders Equity	12.42B	11.65B	11.07B	10.49B	11.75B	11.27B	10.37B	10.16B	9.71B	9.17B	9.17B	8.77B	9.11B	8.89B	8.94B	8.88B	8.86B	8.69B	8.5B	8.2B	8.06B
Total Investments	39.7M	34.9M	28.9M	26.8M	47.8M	64M	44.4M	105.4M	110.3M	198.3M	306.2M	449.5M	1.08B	889.7M	979M	902M	749M	327M	550.88M	582.5M	317.35M